Stock Name : Bharat Immunologicals and Biologicals Corporation Limited/Tips Open Buy : 57 Posted Date : Jan 10, 2021
Stopless/Horizon : 55 Target : 65     

Overview:Bharat Immunological & Biologicals Corporation Ltd(BIBCOL)is a leading biotechnology company based in Uttar Pradesh Indi.It is a Small Cap company with a market capital of Rs 223.67 Crore.

About the company:With the aim to achieve self-sufficiency for the country with respect to production and supply of polio vaccine, the Indian government established BIBCOL in 1989.

Since then, BIBCOLhas contributed significantly to the eradication of Poliomyelitis in the country by supplying billons of doses of oral polio vaccine. Currently, the company is the pioneer in the field of polio vaccines with 60% of total market share in India.

Apart from Oral Polio Vaccines (OPV Vaccine), BIBCOL manufactures a range of pharmaceuticals products including Zinc Tablet & Diarrheal Management Kit, Ready to Use Therapeutic Food and IFA Tablets.

BIBCOL derives orders for OPV through tenders floatedby the Central government for the National Immunization and Pulse Polio Program.

The company’s competitors (from private companies)include Panacea Biotec, Bio-Med Private Limited, Haffkine Bio-Pharmceutical Corporation Ltd. and Bharat Biotech.

The Company’s manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh.

Management:BIBCOL is a Public Sector Undertaking (PSU) of the Government of India, it is under the administrative control of the Department of Biotechnology, Ministry of Science and Technology.Dr Y K Gupta is the chairman and Mr Chandra Prakash Goyal is the Managing Director.

Shareholding Pattern (2020):
• Promoter: 59.25%
• Public: 40.75%

Sales Report: For the quarter ended 30th June 2020, BIBCOL reported a Standalone sale of Rs 25.36Crore, which is down -17.63 % compared to the previous quarter Sales of Rs 23.25 Crore, but up by 173.62 % from last year’s corresponding period’s Sales of Rs 7.00 Crore.

If you find any mistake please contact the This article is general in nature. It does not constitute a recommendation to buy and sell any stock, and does not take account of your objectives, or your financial situation. Largecapindia has no position in the stocks mentioned.

Largecapindia aim to bring you long term focused research analysis driven by fundamental thanks you.

For More Info :